PEPTIDE REAGENTS AND METHODS FOR DETECTION AND TARGETING OF DYSPLASIA, EARLY CANCER AND CANCER
First Claim
Patent Images
1. A reagent consisting essentially of a peptide QRHKPRE (SEQ ID NO:
- 1), HAHRSWS (SEQ ID NO;
2), YLTMPTP (SEQ ID NO;
3), TYPISFM (SEQ ID NO;
4), KLPGWSG (SEQ ID NO;
5), IQSPHFF (SEQ ID NO;
6), YSIPKSS (SEQ ID NO;
7), SHRNRPRNTQPS (SEQ ID NO;
8), NRHKPREKTFTD (SEQ ID NO;
9), TAVPLKRSSVTI (SEQ ID NO;
10), GHTANRQPWPND (SEQ ID NO;
11), LSLTRTRHRNTR (SEQ ID NO;
12), RHRDTQNHRPTN (SEQ ID NO;
13), ARHRPKLPYTHT (SEQ ID NO;
14), KRPRTRNKDERR (SEQ ID NO;
15), SPMPQLSTLLTR (SEQ ID NO;
16) or NHVHRMHATPAY (SEQ ID NO;
17).or a multimer form of the peptide, wherein the peptide specifically binds to epidermal growth factor receptor.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to EGFR-specific peptide reagents, methods for detecting pre-cancer, early cancer and/or cancer using the peptide reagents, and methods for targeting pre-cancer cells, early cancer cells and/or cancer cells using the peptide reagents. In one aspect, the disclosure provides reagents consisting essentially of a peptide QRHKPRE (SEQ ID NO: 1), HAHRSWS (SEQ ID NO: 2), YLTMPTP (SEQ ID NO: 3), TYPISFM (SEQ ID NO: 4), KLPGWSG (SEQ ID NO: 5), IQSPHFF (SEQ ID NO: 6), YSIPKSS (SEQ ID NO: 7), SHRNRPRNTQPS (SEQ ID NO: 8), NRHKPREKTFTD (SEQ ID NO: 9).
0 Citations
26 Claims
-
1. A reagent consisting essentially of a peptide QRHKPRE (SEQ ID NO:
- 1), HAHRSWS (SEQ ID NO;
2), YLTMPTP (SEQ ID NO;
3), TYPISFM (SEQ ID NO;
4), KLPGWSG (SEQ ID NO;
5), IQSPHFF (SEQ ID NO;
6), YSIPKSS (SEQ ID NO;
7), SHRNRPRNTQPS (SEQ ID NO;
8), NRHKPREKTFTD (SEQ ID NO;
9), TAVPLKRSSVTI (SEQ ID NO;
10), GHTANRQPWPND (SEQ ID NO;
11), LSLTRTRHRNTR (SEQ ID NO;
12), RHRDTQNHRPTN (SEQ ID NO;
13), ARHRPKLPYTHT (SEQ ID NO;
14), KRPRTRNKDERR (SEQ ID NO;
15), SPMPQLSTLLTR (SEQ ID NO;
16) or NHVHRMHATPAY (SEQ ID NO;
17).or a multimer form of the peptide, wherein the peptide specifically binds to epidermal growth factor receptor. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 14, 15, 16, 17, 18, 25)
- 1), HAHRSWS (SEQ ID NO;
- 12. The reagent of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11 comprising a therapeutic moiety attached to the peptide.
-
26. A peptide consisting of the amino acid sequence QRHKPRE (SEQ ID NO:
- 1), HAHRSWS (SEQ ID NO;
2), TYPISFM (SEQ ID NO;
4), SHRNRPRNTQPS (SEQ ID NO;
8), NRHKPREKTFTD (SEQ ID NO;
9), TAVPLKRSSVTI (SEQ ID NO;
10), GHTANRQPWPND (SEQ ID NO;
11), LSLTRTRHRNTR (SEQ ID NO;
12), RHRDTQNHRPTN (SEQ ID NO;
13), ARHRPKLPYTHT (SEQ ID NO;
14) or KRPRTRNKDERR (SEQ ID NO;
15).
- 1), HAHRSWS (SEQ ID NO;
Specification